Virginia Schad

PharmD

Most Recent Articles by Virginia Schad

Dual Regimen Provides Simple and Safe Salvage Therapy in HIV-1

Dual Regimen Provides Simple and Safe Salvage Therapy in HIV-1

By

Switching to dolutegravir plus darunavir/ritonavir provided a simple and safe rescue regimen, controlling viral replication in a high proportion of patients.

A New Treatment Option for Patients With HCV and Severe Renal Impairment

A New Treatment Option for Patients With HCV and Severe Renal Impairment

By

Glecaprevir, an NS3/4A protease inhibitor, and pibrentasvir, an NS5A inhibitor, exhibit potent antiviral activity across all six major HCV genotypes.

Weight-Based Dosing of Clindamycin and TMP/SMX Improves Cellulitis Outcomes

Weight-Based Dosing of Clindamycin and TMP/SMX Improves Cellulitis Outcomes

By

Weight-based dosing options for treatment may improve clinical outcomes in patients with cellulitis.

Efficacy of Ravidasvir Plus Sofosbuvir for Chronic Hepatitis C Genotype 4

Efficacy of Ravidasvir Plus Sofosbuvir for Chronic Hepatitis C Genotype 4

By

Researchers believe new once-daily dose of ravidasvir plus sofosbuvir is effective in treatment HCV genotype-4 and may be cost effective.

Direct-Acting Antivirals: The Gold Standard for HCV Recurrence Following Transplantation?

Direct-Acting Antivirals: The Gold Standard for HCV Recurrence Following Transplantation?

By

The majority of patients treated with second-generation direct-acting antiviral agents achieved sustained virologic response in 12 weeks.

Sign Up for Free e-newsletters